Incidence of Neurological Syndromes After Thrombolytic Therapy In Elderly Patients With Acute Myocardial Infarction

Background: Reperfusion therapy is the standard treatment of acute myocardial infarction (AMI). If the percutaneous coronary intervention (PCI), as a preferred reperfusion strategy, was not available, thrombolytic therapy is chosen as an alternative treatment. However, the affect of thrombolytic th...

Full description

Bibliographic Details
Main Authors: Hassan Shemirani, Seyyedeh Fatemeh Bahari Saravi
Format: Article
Language:fas
Published: Isfahan University of Medical Sciences 2008-06-01
Series:مجله دانشکده پزشکی اصفهان
Online Access:http://jims.mui.ac.ir/index.php/jims/article/view/176
_version_ 1797759852848611328
author Hassan Shemirani
Seyyedeh Fatemeh Bahari Saravi
author_facet Hassan Shemirani
Seyyedeh Fatemeh Bahari Saravi
author_sort Hassan Shemirani
collection DOAJ
description Background: Reperfusion therapy is the standard treatment of acute myocardial infarction (AMI). If the percutaneous coronary intervention (PCI), as a preferred reperfusion strategy, was not available, thrombolytic therapy is chosen as an alternative treatment. However, the affect of thrombolytic therapy in old patients is still controversial; especially because of its effects on increasing the incidence of intra cranial hemorrhage (ICH). In this study, we evaluated the incidence of neurological symptoms and ICH after thrombolytic therapy in more than 65 years old patients with AMI. Methods: 300 patients of 65 years old and more with AMI in which their symptoms had been begun more than 12 hours before admission to the hospital, and with no contraindications for receiving thrombolytic therapy, were chosen. The patients were admitted in Noor hospital between 2004 and 2006. All of them received streptokinase (SK) in the same way, and the information's were pulled out from their files and gathered in a check list. Findings: Among 300 patients in our study, there were 124 women (41/33%) and 176 men (58/66%). Their mean age was (74±9) years (from 65 to 92 years). 78% were discharged after one week hospitalization and 22% (66 patients) died. Arrhythmias or myocardial re-infarction were the leading cause of death in 56/06% of all deaths. No death due to ICH and no evidence of ICH, such as hemi-paresis or loss of consciousness, were occurred. Conclusion: We suggest that thrombolytic therapy in old patients with acute myocardial infarction is a good alternative treatment when there is no ready access to a skilled PCI facility. In our study, increasing of mortality rate due to ICH was not enough to exclude giving SK to more than 65 years old patients. Key words: Acute myocardial infarction, percutaneous coronary intervention, intracranial hemorrhage, streptokinase, thrombolytic therapy
first_indexed 2024-03-12T18:50:26Z
format Article
id doaj.art-4a63790011e9481e949de3ce3ead1e73
institution Directory Open Access Journal
issn 1027-7595
1735-854X
language fas
last_indexed 2024-03-12T18:50:26Z
publishDate 2008-06-01
publisher Isfahan University of Medical Sciences
record_format Article
series مجله دانشکده پزشکی اصفهان
spelling doaj.art-4a63790011e9481e949de3ce3ead1e732023-08-02T07:15:46ZfasIsfahan University of Medical Sciencesمجله دانشکده پزشکی اصفهان1027-75951735-854X2008-06-0126888591173Incidence of Neurological Syndromes After Thrombolytic Therapy In Elderly Patients With Acute Myocardial InfarctionHassan Shemirani0Seyyedeh Fatemeh Bahari Saravi1Associate Professor of Cardiology, School of Medicine, University of Medical SciencesMedical Student, School of Medicine, Isfahan, University of Medical SciencesBackground: Reperfusion therapy is the standard treatment of acute myocardial infarction (AMI). If the percutaneous coronary intervention (PCI), as a preferred reperfusion strategy, was not available, thrombolytic therapy is chosen as an alternative treatment. However, the affect of thrombolytic therapy in old patients is still controversial; especially because of its effects on increasing the incidence of intra cranial hemorrhage (ICH). In this study, we evaluated the incidence of neurological symptoms and ICH after thrombolytic therapy in more than 65 years old patients with AMI. Methods: 300 patients of 65 years old and more with AMI in which their symptoms had been begun more than 12 hours before admission to the hospital, and with no contraindications for receiving thrombolytic therapy, were chosen. The patients were admitted in Noor hospital between 2004 and 2006. All of them received streptokinase (SK) in the same way, and the information's were pulled out from their files and gathered in a check list. Findings: Among 300 patients in our study, there were 124 women (41/33%) and 176 men (58/66%). Their mean age was (74±9) years (from 65 to 92 years). 78% were discharged after one week hospitalization and 22% (66 patients) died. Arrhythmias or myocardial re-infarction were the leading cause of death in 56/06% of all deaths. No death due to ICH and no evidence of ICH, such as hemi-paresis or loss of consciousness, were occurred. Conclusion: We suggest that thrombolytic therapy in old patients with acute myocardial infarction is a good alternative treatment when there is no ready access to a skilled PCI facility. In our study, increasing of mortality rate due to ICH was not enough to exclude giving SK to more than 65 years old patients. Key words: Acute myocardial infarction, percutaneous coronary intervention, intracranial hemorrhage, streptokinase, thrombolytic therapyhttp://jims.mui.ac.ir/index.php/jims/article/view/176
spellingShingle Hassan Shemirani
Seyyedeh Fatemeh Bahari Saravi
Incidence of Neurological Syndromes After Thrombolytic Therapy In Elderly Patients With Acute Myocardial Infarction
مجله دانشکده پزشکی اصفهان
title Incidence of Neurological Syndromes After Thrombolytic Therapy In Elderly Patients With Acute Myocardial Infarction
title_full Incidence of Neurological Syndromes After Thrombolytic Therapy In Elderly Patients With Acute Myocardial Infarction
title_fullStr Incidence of Neurological Syndromes After Thrombolytic Therapy In Elderly Patients With Acute Myocardial Infarction
title_full_unstemmed Incidence of Neurological Syndromes After Thrombolytic Therapy In Elderly Patients With Acute Myocardial Infarction
title_short Incidence of Neurological Syndromes After Thrombolytic Therapy In Elderly Patients With Acute Myocardial Infarction
title_sort incidence of neurological syndromes after thrombolytic therapy in elderly patients with acute myocardial infarction
url http://jims.mui.ac.ir/index.php/jims/article/view/176
work_keys_str_mv AT hassanshemirani incidenceofneurologicalsyndromesafterthrombolytictherapyinelderlypatientswithacutemyocardialinfarction
AT seyyedehfatemehbaharisaravi incidenceofneurologicalsyndromesafterthrombolytictherapyinelderlypatientswithacutemyocardialinfarction